# Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain Patients

> **NCT01014559** · PHASE3 · TERMINATED · sponsor: **Mundipharma SAS** · enrollment: 225 (actual)

## Conditions studied

- Constipation
- Pain

## Interventions

- **DRUG:** Oxycodone Naloxone
- **DRUG:** Oxycodone PR Tablets

## Key facts

- **NCT ID:** NCT01014559
- **Lead sponsor:** Mundipharma SAS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2011-06
- **Final completion:** 2013-02
- **Target enrollment:** 225 (ACTUAL)
- **Why stopped:** Lack of recruitment
- **Last updated:** 2015-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01014559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01014559, "Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01014559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*